美国 · 股市与财经 · Morningstar

Antengene to Present Latest Preclinical Results of Novel Cos-TCE Platform in Rapid Oral Abstract Presentation at SITC 2026

来源：Morningstar · 美国 8 小时前

Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) is a global, R&D-driven, commercial-stage biotech company focused on developing first-in-class/best-in ...

在 Morningstar 阅读全文登录后可收藏

MediaNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.morningstar.com)

Antengene to Present Latest Preclinical Results of Novel Cos-TCE Platform in Rapid Oral Abstract Presentation at SITC 2026

推荐阅读

Federal Watchdog Investigates Adam Kinzinger for Kalshi Bets on His Pardon

Power Play

Oil prices drop as G7 nations pledge to release diesel stocks; Saudis said planning attack on Houthis

OpenAI safety leader David Robinson resigns as the team's upheaval mounts

Cerebras stock hits post-IPO low, tumbling 20% for the week on Nvidia pressure and lockup expiration

Trump Says South Korea Deal Includes $8.4 Billion U.S. Oil Project

Antengene to Present Latest Preclinical Results of Novel Cos-TCE Platform in Rapid Oral Abstract Presentation at SITC 2026

分享

推荐阅读

Federal Watchdog Investigates Adam Kinzinger for Kalshi Bets on His Pardon

Power Play

Oil prices drop as G7 nations pledge to release diesel stocks; Saudis said planning attack on Houthis

OpenAI safety leader David Robinson resigns as the team's upheaval mounts

Cerebras stock hits post-IPO low, tumbling 20% for the week on Nvidia pressure and lockup expiration

Trump Says South Korea Deal Includes $8.4 Billion U.S. Oil Project